Search

Search Constraints

You searched for: Author/Creator Sonke, Gabe

Search Results

1. 2022-RA-1267-ESGO A randomised clinical Trial Investigating olaparib, durvalumab and an anticancer vaccine, UV1 as maintenance therapy in patients with recurrent ovarian cancer. ENGOT-OV56-NSGO-CTU-DOVACC. (20th October 2022)

2. 45/#732 Homologous recombination deficiency and cyclin E1 amplification are correlated with immune cell infiltration and survival in high-grade serous ovarian cancer. (4th December 2022)

4. Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer. Issue 12 (12th October 2020)

5. Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy. (November 2020)

6. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. Issue 6 (20th June 2019)

7. Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data. Issue 13 (4th September 2018)

9. Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study. Issue 11 (14th November 2017)

10. O027/#273 Use and early postoperative outcomes of hyperthermic intraperitoneal chemotherapy for ovarian cancer in clinical practice. (4th December 2022)